Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Acupressure improves quality of life in PCOS patients.

Spironolactone effectively reduces symptoms of hyperandrogenism but has some side effects.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Spironolactone did not make hair thinner in women with excess hair growth.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Women with PCOS tend to be less optimistic than those without it.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Menopause affects hair and skin; more research needed for treatment.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Coloring white hair before IPL treatment effectively helps remove it.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Women with excessive hair growth often have hormonal issues and need medical advice and treatment.

PCOS is a common hormonal disorder in women that can be managed with lifestyle changes and various medications.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Excessive hair growth is much more common in Chinese women with PCOS than in the general population.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

The photographic method accurately measures hair growth and both treatments effectively reduced hair growth in hirsute women.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

Spironolactone is effective for idiopathic hirsutism but has limited effects on other PCOS symptoms.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Neem and Zanjabeel are as effective as standard drugs for treating hirsutism in PCOD patients.